Abstract:Radiotherapy is the key treatment for non-operative locally advanced squamous carcinoma of the esophagus. In practice, few patients with in-field recurrent esophageal cancer after the primary definitive concurrent chemo-radiotherapy (dCCRT) had possibility of salvage surgery due to poorly general conditions and post-radiotherapy local tissue fibrosis. For patients with good performance status, re-irradiation was one of the potential treatment options. So far, the role of re-irradiation and the impacts of chemotherapy among such patients remain unclear. Between Oct 2008 and Dec 2016, 98 patients with in-field recurrent esophageal squamous cell carcinomas after dCCRT were identified and retrospectively analyzed. Among these patients, 48 patients received re-irradiation alone (re-RT), and another 50 patients received re-irradiation combined with chemotherapy (re-RCT). Statistical analyses were performed with SPSS 26.0. The chi-square test was used to compare the treatment-related complications between the two groups. Survival time was performed using the Kaplan-Meier method. Log-rank test was applied to compare survival rates. Potential prognostic variables were estimated using multi-variate Cox regression model. The p value was considered statistically significant if less than 0.05. In present study, the response rates were 56.3% (27/48) and 72.0% (36/50) in re-RT and re-RCT group respectively (p = 0.104). While, the median progression-free survival (PFS) and overall survival (OS) in re-RT group and re-RCT group were 10.0/15.0 months and 11.3/15.6 months respectively (p = 0.236/0.455). Grade 3 and above toxicities included radiation-induced esophagitis (21.4%), radiation pneumonitis (15.3%), gastrointestinal dysfunction (total 22.4%; 10.4%/34.0% in re-RT and re-RCT group respectively, p = 0.005), neutropenia (total 28.6%; 14.6%/42.0% in re-RT and re-RCT group respectively, p = 0.003), thrombocytopenia (6.1%) and anemia (9.2%). The incidences of treatment-related esophageal fistula in re-RT group and re-RCT group were 12.5% (6/48)/12.0% (6/50) respectively (p>0.05). Re-irradiation was an effective treatment for patients with locally in-field recurrent esophageal cancer after initial dCCRT. Compared with the radiotherapy alone, radio-chemotherapy did not improve PFS and OS among such patients. The incidence of treatment-related esophageal fistula was common, and should be seriously evaluated in clinical practice. Considering the retrospective nature of present study, perspective randomized trials are warranted in future.

Radiobiological modeling of acute esophagitis after radiation therapy of head, neck, and thorax tumors: The influence of chemo-radiation

Early Prediction of Acute Esophagitis for Adaptive Radiation Therapy

Predictive model for acute radiation esophagitis in esophageal carcinoma based on prognostic nutritional index and systemic inflammatory index and its application

Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review

Factors associated with acute esophagitis during radiation therapy for lung cancer

Risk Factors for Acute Esophagitis in Non–small-Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Three-Dimensional Conformal Radiotherapy

On Predicting Clinical Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Additional Evaluation by Magnetic Resonance Imaging May Help

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy

Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients

Different Radiation Treatment in Esophageal Carcinoma: a Clinical Comparative Study.

Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer

Estimating the Dose-Response Relationship for Ocular Pain after Radiotherapy of Head and Neck Cancers and Skull Base Tumors based on the LKB Radiobiological Model

TU-C-12A-09: Modeling Pathologic Response of Locally Advanced Esophageal Cancer to Chemo-Radiotherapy Using Quantitative PET/CT Features, Clinical Parameters and Demographics.

Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma

Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis

Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review.

Long Term Results of Different Radiotherapy Techniques and Fractions for Esophageal Squamous Cell Carcinoma

Risk Prediction Model for Radiation-Induced Dermatitis in Patients with Cervical Carcinoma undergoing Chemoradiotherapy

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis

Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer

Re-irradiation with or Without Chemotherapy for In-field Local Recurrence among Esophageal Cancer Patients after Initial Definitive Concurrent Chemo-radiotherapy